Summary

The cell sorting market is expected to register a CAGR of nearly 7.3%, during the forecast period.

Due to the pandemic, all the research and development programs have been only for developing drugs and vaccines related to the coronavirus and all other programs have come to halt. many biotech and pharma companies have stopped producing due to the lack of labor during the lockdown, globally. The growing market has not been as expected due to the disruption of research programs and less procurement of cell sorters by the companies.

The cell sorting market will show rapid growth due to the growing prevalence of HIV and cancer, expanding pharmaceutical and biotechnology industries, and technological advancements in cell sorters.

HIV continues to be a major global public health issue. The vast majority of people living with HIV are located in low- and middle-income countries. According to UnAIDs, 2020 estimates, around 38.0 million people globally have AIDS as of 2019. 1.7 million got newly infected.

Over the years, cell sorting was combined with molecular biological techniques and proteomics for characterizing metastatic & primary cancer cell populations and single tumor cells. According to Globocan, 19.29 million people got newly diagnosed by cancer for the year 2020. In 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 606,520 people will die due to the disease as per National Cancer Institute. With the growing prevalence of cancer the demand for cell sorters also increase for characterizing tumors.

However, the high cost of the devices and the lack of awareness of the advantages of these cell sorters restrain the market in the forecast period.

Key Market Trends

Fluorescence-Based Droplet Cell Sorting (FACS) is Expected to be the Largest Growing Segment in the Cell Sorting Market

The fluorescence-based Droplet Cell Sorting segment is expected to grow during the forecast period due to it being highly accurate and precise sorting method. It is essential in numerous biological assays requiring high-throughput analysis and sorting of single cells. The gold standard technology for this purpose is fluorescence-activated cell sorting (FACS).

It provides a method of filtering a mixture of living cells in two or more vessels, one cell at a time, based on light scattering light and fluorescent features of each cell. It is a useful scientific tool, as it provides a fast, purposeful, and balanced recording of fluorescent signals from individual cells as well as the body classification of specific cells of interest.

FACS is thus anticipated to be the segment driving the growth of the Cell Sorting market during the forecast period owing to its accuracy and increasing applications. In addition, it offers higher purity and recovery of cells as compared to other methods, though the cells are lost due to mortality.

Moreover the growing incidence of diseases like HIV and cancers are increasing the demand for these devices. The International Agency for Research on Cancer 2020, estimates , that worldwide, 1 person in 5 develops cancer at some point in life, and 1 in 8 men and 1 in 11 women die from the disease. These new estimates show that more than 50 million people live within five years of a previous cancer diagnosis for the year 2020. The number of older people worldwide and the economic and economic pressures remain among the factors contributing to this increase. The growing population of the patients needing diagnosis is increasing the segment growth.

North America is Found Leading the Cell Sorting Market

North America has dominated the market due to the high investments in the pharmaceutical & biotechnology industries and the increasing adoption of this technique in cancer research, as well as the development of new therapeutics in countries such as the U.S.

In addition, the rising incidence of cancer and other infectious diseases in the country drives regional growth. According to the Centers for Disease Control and Prevention, 2020, a number of visits to physician offices with infectious and parasitic diseases as the primary diagnosis was 15.5 million for the year 2018 in the country. The increasing rates of cancer and diseases that require cell sorting and the increasing healthcare expenditure in the country boost the market growth in the region.

The Cell Sorting market growth in these regions can be attributed to advanced research infrastructures, significant health care spending, and increase government funding for research. According to Patented Medicine Prices Review Board - Annual Report 2018, the pharma expenditure in Canada increased from 0.79 million Canadian dollars in 2014 to 0.89 million Canadian dollars in 2018. The incresae in the fundings and the rising prevalence of chronic diseases boost the market growth in the region.

Competitive Landscape

There has been a presence of a considerable number of companies that are mainly focusing on agreements and expansions to strengthen their business operations. Key companies are engaged in significant strategic initiatives such as regional expansion, product development, and strategic collaborations & partnerships. Some of the major players are Becton, Dickinson and Company, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc. (Danaher Corporation) etc.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

ページTOPに戻る

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of HIV and Cancer
4.2.2 Expanding Pharmaceutical and Biotechnology Industries
4.2.3 Technological Advancements in Cell Sorters
4.3 Market Restraints
4.3.1 High Cost of Cell Sorting Instruments
4.3.2 Lack of Awareness Regarding the Use of Cell Sorters
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Technology
5.1.1 Fluorescence-Based Droplet Cell Sorting
5.1.2 Magnetic-Activated Cell Sorting (MACS)
5.1.3 Micro-Electromechanical Systems (MEMS) - Microfluidics
5.2 By Product & Service
5.2.1 Cell Sorters
5.2.2 Cell Sorting Reagents and Consumables
5.2.3 Cell Sorting Services
5.3 By End User
5.3.1 Research Institutions
5.3.2 Pharmaceutical and Biotechnology Companies
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Beckman Coulter, Inc. (Danaher Corporation)
6.1.3 Bio-Rad Laboratories, Inc.
6.1.4 Sony Biotechnology Inc. (Sony Corporation of America)
6.1.5 Miltenyi Biotec GmbH
6.1.6 Affymetrix, Inc. (Thermo Fisher Scientific )
6.1.7 Sysmex Partec GmbH (Sysmex Corporation)
6.1.8 On-Chip Biotechnologies Co., Ltd.
6.1.9 Cytonome/St, LLC
6.1.10 Union Biometrica, Inc.
6.1.11 NanoCellect Biomedical
6.1.12 Namocell Inc.
6.1.13 Bulldog Bio Inc.
6.1.14 Cell Microsystems, Inc.
6.1.15 Molecular Devices LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS